Photocure $PHO.OL stock pullback after Q2 is chance to buy

7 ago 2019

Photocure $PHO.OL PHO presented Q2 2019 numbers today, with most numbers landing very close to expectations.

Webcast: https://webtv.hegnar.no/presentation.php?webcastId=98041425

Press release: https://newsweb.oslobors.no/message/482310

Armchair Healthcare podcast interview with CEO Dan Schneider: https://twitter.com/MaxJacobsEdison/status/1151116879089586176

14 ago 2019

Trade attivo

Trade very much active after two analyst BUY recommendations this week:
Edison, target price NOK 69.
Norne securities, target price NOK 64.

At the current shareprice of NOK 53 this represents a reasonable upside potential.

5 ott 2019

Trade attivo

Trade still active, coming into a crucial phase where either a stop or new upwards movement can be triggered

21 ott 2019

Trade attivo

With crucial Q3 presentation coming up, PHO still trades within clearly defined trading range.

Nice update from company today:
photocure.com/news/siu2019_athens/

6 nov 2019

Trade chiuso: obiettivo raggiunto

Safe choice is to end this trade today before Photocure Q3 presentation, as the stock has been known to make some drastic biotech sell the news moves.

We can note a nice 49 to 59 NOK swing on this trade.